Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kentucky for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kentucky only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kentucky (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Vidya Seshadri (NPI 1184843369)

Field	Value
Entity Type	Individual
Organization	Vidya Seshadri
Address	201 Park St
City	Bowling Green
State	KY
ZIP	42101
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 25, 2007

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the dataset: total Medicare revenue is $2.1M and there is no Medicaid billing on file. That concentration means analyses of utilization and contracting should be focused on Medicare patterns rather than dual‑payer mixes.

Revenue is highly concentrated in three drugs: J9271, J9144 and J0897 together account for 79.1% of this provider's Medicare revenue. Individually these codes appear as J9271 (23.8K claims, $35 avg paid/claim, $833K revenue, 42.2% of Medicare revenue), J9144 (12.2K claims, $38 avg paid/claim, $465.1K revenue, 23.5% of Medicare revenue), and J0897 (14.8K claims, $18 avg paid/claim, $265.7K revenue, 13.4% of Medicare revenue).

The code mix identifies an oncology‑infusion business model centered on high‑use biologics and immunotherapies: pembrolizumab (J9271) and daratumumab (J9144) are the top revenue drivers, and denosumab (J0897) provides a large supplemental share consistent with bone‑health management in oncology. Supporting activity in chemotherapy administration (96413, 96401, 96417) and frequent infusion/IV administration codes (96365, 96375) reinforces that the practice primarily delivers in‑office parenteral cancer therapies.

Clinical throughput includes substantial office evaluation volume and ancillary diagnostics: the practice reported 99214 (683 claims, $88 avg paid/claim, $60.1K revenue) and 99215 (253 claims, $126 avg paid/claim, $31.9K revenue), alongside high lab panel and CBC volumes (80053 and 85025 among top codes). This mix indicates regular follow‑up and monitoring visits with a steady stream of laboratory and imaging support tied to active treatment regimens.

Competitive standing across top therapies is mixed: for the highest‑revenue drug J9271 the provider ranks #252 of 1841 nationally (86th percentile) and is described as a typical volume participant, while J9144 ranks #142 of 615 (76th percentile) also at a typical level. By contrast, J0897 ranks #556 of 10057 (94th percentile) and is labeled notably above typical national volume, signaling a relatively strong national presence for denosumab compared with peers.

Several non‑drug codes are notable outliers by percentile and suggest heavier procedural throughput than average peers: 99214 is at the 94th percentile (notably above typical), 96413 is at the 93th percentile (notably above typical), and 96372 is at the 99th percentile (notably above typical). These elevated percentiles point to sustained high volumes of evaluation/management and injection services that underpin the infusion business model.

From a payer or contracting perspective, the heavy revenue dependence on a small set of injectable oncology agents (top three codes = 79.1% of Medicare revenue) creates concentration risk: shifts in utilization, step‑therapy policies, or price benchmarking for these specific HCPCS drugs could materially affect the provider’s Medicare revenue stream. Payers should therefore prioritize utilization management, site‑of‑care policies, and reimbursement terms for J9271, J9144 and J0897 when engaging this provider.

The provider has an established NPI tenure (enumerated 2007-04-25, approximately 19 years ago), indicating a long‑standing practice presence. That longevity, combined with high percentiles on several treatment and monitoring codes, suggests an experienced oncology practice with stable referral and treatment workflows rather than a newly formed operation.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

83 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	23,800	$40	$833K
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	12,240	$40	$465.1K
J0897	Injection, denosumab, 1 mg	14,760	$20	$265.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	680	$90	$60.1K
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	230	$230	$51.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	550	$90	$48.7K
J1437	Injection, ferric derisomaltose, 10 mg	2,700	$20	$43.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	250	$130	$31.9K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	2,160	$10	$21.6K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	2,610	$10	$20.9K

Showing 1–10 of 83

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 83 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kentucky Distribution

Vidya Seshadri — 10 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kentucky

Full comparison — all codes billed, vs. state median

83 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	2	10	20,900	$40	$847.8K
J9144	1	10	12,240	$40	$463.4K
J0897	3	80	2,280	$20	$59.6K
J1437	1	10	2,700	$20	$42.9K
J3490	3	10	50	$370	$27.2K
J0885	3	10	2,560	$10	$20.8K
96413	4	50	100	$90	$16.7K
96401	10	20	200	$50	$14.3K
99214	298	7,230	110	$70	$14.1K
77067	217	240	100	$50	$13.4K

Showing 1–10 of 83

Related Providers

Other providers that share a Tax Identification Number (TIN) with Vidya Seshadri, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Graves Gilbert Clinic PLLC	KY	Specialist	$0	$78M
Neha Pansuria	KY	Rheumatology Physician	$663.6K	$0
Nirav Sheth	KY	Internal Medicine Physician	$620.2K	$0
Johnathon Edge	KY	MOHS-Micrographic Surgery Physician	$559.9K	$0
Wilfred Lumbang	NH	MOHS-Micrographic Surgery Physician	$524.1K	$0
Jerry Roy	KY	Interventional Cardiology Physician	$361.3K	$0
Ronak Chaudhari	KY	Endocrinology, Diabetes & Metabolism Physician	$347.5K	$0
Sandeep Chhabra	KY	Interventional Cardiology Physician	$341.4K	$0
Sherryl Reed	KY	Internal Medicine Physician	$335.7K	$0
Robert Wesley	KY	Family Medicine Physician	$335.5K	$0

Nearby Providers

Other providers in the same ZIP code as Vidya Seshadri, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bowling Green-warren County Community Hospital Corporation	KY	General Acute Care Hospital	$0	$112.1M
District 4 Cdo Program	KY	Supports Brokerage Agency	$0	$54.7M
Encore Of Bowlng Green Adhc LLC	KY	Adult Day Care Clinic/Center	$0	$23.9M
Journeypure Bowling Green LLC	KY	Substance Abuse Rehabilitation Facility	$0	$16.1M
Ky Steps LLC	KY	Community/Behavioral Health Agency	$0	$13.7M
Tj & L Consulting, LLC	KY	Community/Behavioral Health Agency	$0	$11.3M
Julie Gaskill	KY	Oral and Maxillofacial Surgery (Dentist)	$0	$8.9M
Medical Center Ems, L.L.C.	KY	Ambulance	$1.8M	$6.5M
United Seating And Mobility LLC	KY	Customized Equipment (DME)	$0	$7.3M
Commonwealth Health Corporation	KY	Adult Day Care Clinic/Center	$0	$6.8M

Vidya Seshadri — Billing Profile & Reimbursement Data

Sign up for Vidya Seshadri — Billing Profile & Reimbursement Data policy alerts

Vidya Seshadri — Billing Profile & Reimbursement Data

Sign up for Vidya Seshadri — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References